Cargando…
Use of molecular targeted agents for the diagnosis, staging and therapy of neuroendocrine malignancy
Imaging of neuroendocrine tumours (NET) poses significant challenges because of the heterogeneous biology of the tumours that are represented by this class of neoplasia. NET can range from benign lesions to highly aggressive cancers. Structural imaging techniques have suboptimal sensitivity in most...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
e-Med
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967140/ https://www.ncbi.nlm.nih.gov/pubmed/20880795 http://dx.doi.org/10.1102/1470-7330.2010.9007 |